Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 EUR | -0.48% | -7.52% | -3.69% |
04-23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
02-29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Performance
1 day | -0.48% | ||
Current month | -3.69% | ||
Current year | -3.69% | ||
3 years | -13.99% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.48% | -7.52% | -3.69% | - | 214M | ||
+0.53% | +2.36% | +2.34% | +24.63% | 42.75B | ||
-1.02% | +3.08% | +47.70% | -5.60% | 41.61B | ||
+3.40% | +6.55% | +11.92% | -16.57% | 41.34B | ||
+4.02% | +6.25% | -8.83% | +14.38% | 26.59B | ||
-2.15% | +1.31% | +6.63% | +54.44% | 25.49B | ||
+2.97% | +1.08% | -23.01% | -27.00% | 18.12B | ||
+1.00% | +6.06% | +30.18% | +93.25% | 12.24B | ||
+1.10% | -0.55% | -2.17% | +21.66% | 11.76B | ||
+2.20% | +2.53% | +9.14% | +3.39% | 11B | ||
+1.30% | +3.46% | -15.80% | -18.00% | 10.07B | ||
+1.34% | +2.30% | -5.81% | -8.61% | 9.22B | ||
+0.12% | +3.57% | +24.92% | -15.11% | 6.65B | ||
+3.41% | +20.21% | +8.55% | -34.40% | 6.44B | ||
+2.32% | +0.85% | +28.10% | +54.05% | 6.13B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | +1.27% | +3.62% | +7.34% | +10.04% | ||
Weighted average by Cap. | +1.24% | +3.94% | +10.08% | +9.64% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2022 | -2.69% | ||
2021 | -10.80% | ||
2020 | +66.67% | ||
2019 | -.--% |
- Stock Market
- Equities
- XLS Stock
- XLS Stock
- Quotes Xlife Sciences AG